Reducing the dose of radiation to nodal regions is safe and does not impact the risk of recurrence in patients with head and neck cancer, a study suggests.

The FDA has issued a complete response letter to Telix Pharmaceuticals regarding TLX101-CDx for the imaging of gliomas.

New data presented at AACR supports adding pembrolizumab before and after surgery in patients with newly diagnosed locally ...

A reduced dose of elective radiation is safe and does not compromise treatment efficacy in patients with head and neck ...

Memphis Grizzlies players and coaches huddled together for a prayer inside a silent Spectrum Center Arena on Tuesday night against the Charlotte Hornets after rookie forward Jaylen Wells was ...

During the late 1980s, advancements in computer technology and imaging allowed identification ... Such examples include many advanced head and neck cancers, where the targets are anterior and ...